These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7705112)

  • 21. Treatment outcome of combination therapy including clarithromycin for Mycobacterium avium complex pulmonary disease.
    Kim EY; Chi SY; Oh IJ; Kim KS; Kim YI; Lim SC; Kim YC; Kwon YS
    Korean J Intern Med; 2011 Mar; 26(1):54-9. PubMed ID: 21437163
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activity of clarithromycin against Mycobacterium avium infection in patients with the acquired immune deficiency syndrome. A controlled clinical trial.
    Dautzenberg B; Truffot C; Legris S; Meyohas MC; Berlie HC; Mercat A; Chevret S; Grosset J
    Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):564-9. PubMed ID: 1832527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness of the macrolide clarithromycin in the treatment of Mycobacterium avium complex infection in HIV-infected patients.
    Ruf B; Schürmann D; Mauch H; Jautzke G; Fehrenbach FJ; Pohle HD
    Infection; 1992; 20(5):267-72. PubMed ID: 1428183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A retrospective comparison of clarithromycin versus rifampin in combination treatment for disseminated Mycobacterium avium complex disease in AIDS: clarithromycin decreases transfusion requirements.
    Burman WJ; Reves RR; Rietmeijer CA; Cohn DL
    Int J Tuberc Lung Dis; 1997 Apr; 1(2):163-9. PubMed ID: 9441082
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clarithromycin regimens for pulmonary Mycobacterium avium complex. The first 50 patients.
    Wallace RJ; Brown BA; Griffith DE; Girard WM; Murphy DT
    Am J Respir Crit Care Med; 1996 Jun; 153(6 Pt 1):1766-72. PubMed ID: 8665032
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful discontinuation of therapy for disseminated Mycobacterium avium complex infection after effective antiretroviral therapy.
    Shafran SD; Mashinter LD; Phillips P; Lalonde RG; Gill MJ; Walmsley SL; Toma E; Conway B; Fong IW; Rachlis AR; Williams KE; Garber GE; Schlech WF; Smaill F; Pradier C
    Ann Intern Med; 2002 Nov; 137(9):734-7. PubMed ID: 12416943
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intermittent antibiotic therapy for nodular bronchiectatic Mycobacterium avium complex lung disease.
    Jeong BH; Jeon K; Park HY; Kim SY; Lee KS; Huh HJ; Ki CS; Lee NY; Shin SJ; Daley CL; Koh WJ
    Am J Respir Crit Care Med; 2015 Jan; 191(1):96-103. PubMed ID: 25393520
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Repeat positive cultures in Mycobacterium intracellulare lung disease after macrolide therapy represent new infections in patients with nodular bronchiectasis.
    Wallace RJ; Zhang Y; Brown-Elliott BA; Yakrus MA; Wilson RW; Mann L; Couch L; Girard WM; Griffith DE
    J Infect Dis; 2002 Jul; 186(2):266-73. PubMed ID: 12134265
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clarithromycin therapy for bacteremic Mycobacterium avium complex disease. A randomized, double-blind, dose-ranging study in patients with AIDS. AIDS Clinical Trials Group Protocol 157 Study Team.
    Chaisson RE; Benson CA; Dube MP; Heifets LB; Korvick JA; Elkin S; Smith T; Craft JC; Sattler FR
    Ann Intern Med; 1994 Dec; 121(12):905-11. PubMed ID: 7978715
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized, open-label trial of azithromycin plus ethambutol vs. clarithromycin plus ethambutol as therapy for Mycobacterium avium complex bacteremia in patients with human immunodeficiency virus infection. Veterans Affairs HIV Research Consortium.
    Ward TT; Rimland D; Kauffman C; Huycke M; Evans TG; Heifets L
    Clin Infect Dis; 1998 Nov; 27(5):1278-85. PubMed ID: 9827282
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized comparison of two clarithromycin doses for treatment of Mycobacterium avium complex infections.
    Dautzenberg B; Truffot-Pernot C; Hazebroucq J; Legris S; Guérin C; Begelman C; Guermonprez G; Fievet MH; Chastang C; Grosset J
    Infection; 1997; 25(1):16-21. PubMed ID: 9039532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of combination therapy regimens for treatment of human immunodeficiency virus-infected patients with disseminated bacteremia due to Mycobacterium avium. ANRS Trial 033 Curavium Group. Agence Nationale de Recherche sur le Sida.
    May T; Brel F; Beuscart C; Vincent V; Perronne C; Doco-Lecompte T; Saint-Marc T; Dautzenberg B; Grosset J
    Clin Infect Dis; 1997 Sep; 25(3):621-9. PubMed ID: 9314450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors that affect sputum conversion and treatment outcome in patients with Mycobacterium avium-intracellulare complex pulmonary disease.
    Ye JJ; Wu TS; Chiang PC; Lee MH
    J Microbiol Immunol Infect; 2007 Aug; 40(4):342-8. PubMed ID: 17712469
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized trial of clarithromycin as prophylaxis against disseminated Mycobacterium avium complex infection in patients with advanced acquired immunodeficiency syndrome.
    Pierce M; Crampton S; Henry D; Heifets L; LaMarca A; Montecalvo M; Wormser GP; Jablonowski H; Jemsek J; Cynamon M; Yangco BG; Notario G; Craft JC
    N Engl J Med; 1996 Aug; 335(6):384-91. PubMed ID: 8663871
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clarithromycin. A review of its pharmacological properties and therapeutic use in Mycobacterium avium-intracellulare complex infection in patients with acquired immune deficiency syndrome.
    Barradell LB; Plosker GL; McTavish D
    Drugs; 1993 Aug; 46(2):289-312. PubMed ID: 7691518
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of pulmonary disease caused by Mycobacterium avium complex.
    Shimokata K
    Intern Med; 2003 Aug; 42(8):627-8. PubMed ID: 12924480
    [No Abstract]   [Full Text] [Related]  

  • 37. Mycobacterium avium complex pulmonary disease: management options in HIV-negative patients.
    Ramirez J; Mason C; Ali J; Lopez FA
    J La State Med Soc; 2008; 160(5):248-54; quiz 254, 293. PubMed ID: 19048978
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in serum immunomolecules during antibiotic therapy for Mycobacterium avium complex lung disease.
    Kim SY; Koh WJ; Park HY; Jeon K; Kwon OJ; Cho SN; Shin SJ
    Clin Exp Immunol; 2014 Apr; 176(1):93-101. PubMed ID: 24354934
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors related to response to intermittent treatment of Mycobacterium avium complex lung disease.
    Lam PK; Griffith DE; Aksamit TR; Ruoss SJ; Garay SM; Daley CL; Catanzaro A
    Am J Respir Crit Care Med; 2006 Jun; 173(11):1283-9. PubMed ID: 16514112
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clarithromycin treatment for Mycobacterium avium-intracellulare complex lung disease.
    Frothingham R
    Am J Respir Crit Care Med; 1996 Jun; 153(6 Pt 1):1990-1. PubMed ID: 8665069
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.